PT82132B - Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas - Google Patents

Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas

Info

Publication number
PT82132B
PT82132B PT82132A PT8213286A PT82132B PT 82132 B PT82132 B PT 82132B PT 82132 A PT82132 A PT 82132A PT 8213286 A PT8213286 A PT 8213286A PT 82132 B PT82132 B PT 82132B
Authority
PT
Portugal
Prior art keywords
sequence
complementary
polympeptides
aminoacides
nucleotid
Prior art date
Application number
PT82132A
Other languages
English (en)
Other versions
PT82132A (en
Inventor
J Edwin Blalock
Eric M Smith
Kenneth L Bost
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of PT82132A publication Critical patent/PT82132A/pt
Publication of PT82132B publication Critical patent/PT82132B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
PT82132A 1985-03-01 1986-03-03 Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas PT82132B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
PT82132A PT82132A (en) 1986-04-01
PT82132B true PT82132B (pt) 1989-05-31

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82132A PT82132B (pt) 1985-03-01 1986-03-03 Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas

Country Status (18)

Country Link
US (2) US5077195A (pt)
EP (2) EP0214232B1 (pt)
JP (1) JPH07215999A (pt)
KR (1) KR920002315B1 (pt)
AT (2) ATE88572T1 (pt)
AU (1) AU592781B2 (pt)
BR (1) BR8606615A (pt)
CA (1) CA1339606C (pt)
DE (2) DE3679017D1 (pt)
DK (1) DK521386A (pt)
ES (3) ES8705919A1 (pt)
FI (1) FI90255C (pt)
GR (1) GR860576B (pt)
IE (1) IE58837B1 (pt)
IL (1) IL96043A0 (pt)
NO (1) NO174971C (pt)
PT (1) PT82132B (pt)
WO (1) WO1986005208A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199801B1 (en) * 1984-10-29 1993-08-25 MICROGENICS CORPORATION (a Delaware corporation) Methods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
EP0294390A1 (en) * 1986-02-19 1988-12-14 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
JPH02104595A (ja) * 1988-03-04 1990-04-17 Univ Alabama 非ペプチドのペプチド相当物及びそのデザイン方法
ATE187738T1 (de) * 1989-07-31 2000-01-15 Tecnogen Scpa Verfahren zur identifizierung und herstellung von bindungsstellen aufeinanderwirkender proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
DE69430190T2 (de) * 1993-10-07 2002-11-21 Kurashiki Boseki Kk Hemmer der aktivität von endothelin
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (de) 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
EP1039931B1 (en) * 1997-12-01 2005-04-27 Fang Fang Multivalent recombinant antibodies for treating hrv infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
AU762711C (en) * 1998-04-24 2004-05-27 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (TCLT)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
US6310041B1 (en) * 1999-03-09 2001-10-30 Fornix Biosciences N.V. Synthetic complementary peptides and ophthalmologic uses thereof
GB2356401A (en) 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
CA2438818C (en) * 2001-02-20 2013-07-02 University Of Georgia Research Foundation, Inc. Rapid production of monoclonal antibodies
CA2454358A1 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
EP2170383A4 (en) * 2007-06-14 2012-12-26 Univ Oklahoma State GENETIC VARIANTS OF DOG PARVOVIRUS CONTAINING VACCINES
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
NO174971C (no) 1994-08-10
FI864427A0 (fi) 1986-10-30
IE58837B1 (en) 1993-11-17
WO1986005208A1 (en) 1986-09-12
ES8800267A1 (es) 1987-11-01
PT82132A (en) 1986-04-01
NO174971B (no) 1994-05-02
KR920002315B1 (ko) 1992-03-21
DK521386D0 (da) 1986-10-31
US5212072A (en) 1993-05-18
ATE88572T1 (de) 1993-05-15
ES8800266A1 (es) 1987-11-01
BR8606615A (pt) 1987-08-11
ATE63138T1 (de) 1991-05-15
DE3679017D1 (de) 1991-06-06
KR870700100A (ko) 1987-02-28
IL96043A0 (en) 1991-07-18
EP0332225B1 (en) 1993-04-21
FI90255C (fi) 1994-01-10
EP0214232B1 (en) 1991-05-02
DK521386A (da) 1986-12-29
ES8705919A1 (es) 1987-05-16
AU592781B2 (en) 1990-01-25
CA1339606C (en) 1997-12-30
EP0214232A1 (en) 1987-03-18
DE3688333T2 (de) 1993-10-28
EP0332225A3 (en) 1989-09-27
NO864369D0 (no) 1986-10-31
US5077195A (en) 1991-12-31
EP0332225A2 (en) 1989-09-13
ES557188A0 (es) 1987-11-01
IE860527L (en) 1986-09-01
ES552534A0 (es) 1987-05-16
DE3688333D1 (de) 1993-05-27
JPH07215999A (ja) 1995-08-15
GR860576B (en) 1986-07-01
AU5510286A (en) 1986-09-24
NO864369L (no) 1987-01-02
ES557189A0 (es) 1987-11-01
FI864427A (fi) 1986-10-30
FI90255B (fi) 1993-09-30

Similar Documents

Publication Publication Date Title
PT82132B (pt) Polipeptidos complementares para peptidos ou proteinas que tem uma sequencia de aminoacidos ou uma sequencia codificadora de nucleotidos pelos menos parcialmente conhecidas
KR910002897A (ko) 에리트로포이에틴(epo)펩타이드 및 이에 대한 항체
ATE177754T1 (de) Fragmente von prion proteinen.
Benjamini et al. Immunochemical studies on the tobacco mosaic virus protein. I. The immunological relationship of the tryptic peptides of tobacco mosaic virus protein to the whole protein
FI854187A0 (fi) Immunoanalyser foer denaturerade proteinanalyser, saerskilt hb alc, samt antikroppar anvaendbara i dessa.
LU91087I2 (fr) Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base.
ES8800274A1 (es) Un procedimiento para la preparacion de un polipeptido-c-terminal p21ras
ES2072423T3 (es) Anticuerpo monoclonal e inmunoensayo para el factor beta xiia de coagulacion de la sangre.
ATE197155T1 (de) Stannius- körperchen -protein, stanniocalcin
PT639225E (pt) Polipeptidos e peptidos novos acidos nucleicos que codificam para aqueles e sua utilizacao na area da terapia tumoral inflamacao ou imunologia
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
ATE161543T1 (de) Aminoterminale prokollagen 1(i) peptide
SE8502722D0 (sv) Sett att bestemma vissa polypeptider samt medel for anvendning derfor
Dixit et al. Biochemical and immunochemical characterization and internal alignment of pepsin-derived collagenous fragments of the alpha 1 (IV) chain from bovine kidney cortices.
DE69333683D1 (de) Antikörper-testbesteck zur bestimmung von amylin
NO984522L (no) Monoklonale antistoffer som binder humant veksthormon (hGH)
BR1100801A (pt) Proteìna, peptìdeo, proteìna ou peptìdeo, sequência de dna, processo para a preparação de uma proteìna ou peptìdeo, anticorpo, composição farmacêutica, e, uso de uma proteìna ou peptìdeo

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980531